NASDAQ: CAMP
Camp4 Therapeutics Corp Stock

$1.50-0.04 (-2.6%)
Updated Jul 11, 2025
CAMP Price
$1.50
Fair Value Price
$2.77
Market Cap
$30.24M
52 Week Low
$1.31
52 Week High
$12.30
P/E
N/A
P/B
0.59x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.22
Operating Cash Flow
N/A
Beta
1.27
Next Earnings
Aug 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CAMP Overview

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CAMP's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
CAMP
Ranked
#177 of 475

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important CAMP news, forecast changes, insider trades & much more!

CAMP News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CAMP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CAMP ($1.50) is undervalued by 45.87% relative to our estimate of its Fair Value price of $2.77 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CAMP ($1.50) is significantly undervalued by 45.87% relative to our estimate of its Fair Value price of $2.77 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CAMP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more CAMP due diligence checks available for Premium users.

Valuation

CAMP fair value

Fair Value of CAMP stock based on Discounted Cash Flow (DCF)

Price
$1.50
Fair Value
$2.77
Undervalued by
45.87%
CAMP ($1.50) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CAMP ($1.50) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

CAMP price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-154.99x
Market
30.99x

CAMP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.59x
Industry
4.62x
CAMP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CAMP's financial health

Profit margin

Revenue
$858.0k
Net Income
-$12.4M
Profit Margin
-1,449.1%

Assets to liabilities

Assets
$62.8M
Liabilities
$11.2M
Debt to equity
0.22
CAMP's short-term assets ($51.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CAMP's short-term assets ($51.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CAMP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$14.3M
Investing
-$279.0k
Financing
-$151.0k

CAMP vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CAMPC$30.24M-2.60%N/A0.59x
ENLV$30.53M-4.48%-1.94x1.48x
DYAI$29.76M-1.10%-4.95x32.22x
FGENC$28.90M-2.72%-2.86x-0.13x
OVID$28.80M-3.34%-1.16x0.49x

Camp4 Therapeutics Stock FAQ

What is Camp4 Therapeutics's quote symbol?

(NASDAQ: CAMP) Camp4 Therapeutics trades on the NASDAQ under the ticker symbol CAMP. Camp4 Therapeutics stock quotes can also be displayed as NASDAQ: CAMP.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.

What is the 52 week high and low for Camp4 Therapeutics (NASDAQ: CAMP)?

(NASDAQ: CAMP) Camp4 Therapeutics's 52-week high was $12.30, and its 52-week low was $1.31. It is currently -87.8% from its 52-week high and 14.94% from its 52-week low.

How much is Camp4 Therapeutics's stock price per share?

(NASDAQ: CAMP) Camp4 Therapeutics stock price per share is $1.50 today (as of Jul 11, 2025).

What is Camp4 Therapeutics's Market Cap?

(NASDAQ: CAMP) Camp4 Therapeutics's market cap is $30.24M, as of Jul 14, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Camp4 Therapeutics's market cap is calculated by multiplying CAMP's current stock price of $1.50 by CAMP's total outstanding shares of 20,161,073.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.